Market Cap : 372.02 M | Enterprise Value : 344.74 M | PE Ratio : 14.61 | PB Ratio : 7.37 |
---|
NAS:CODX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CODX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF margin is calculated as Free Cash Flow divided by its Revenue. Co-Diagnostics's Free Cash Flow for the three months ended in Sep. 2020 was $8.46 Mil. Co-Diagnostics's Revenue for the three months ended in Sep. 2020 was $21.82 Mil. Therefore, Co-Diagnostics's FCF margin for the quarter that ended in Sep. 2020 was 38.76%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Co-Diagnostics's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Co-Diagnostics's FCF Margin for the fiscal year that ended in Dec. 2019 is calculated as
FCF Margin | = | Free Cash Flow (A: Dec. 2019 ) | / | Revenue (A: Dec. 2019 ) |
= | -5.638 | / | 0.215 | |
= | -2,622.33 % |
Co-Diagnostics's FCF Margin for the quarter that ended in Sep. 2020 is calculated as
FCF Margin | = | Free Cash Flow (Q: Sep. 2020 ) | / | Revenue (Q: Sep. 2020 ) |
= | 8.456 | / | 21.819 | |
= | 38.76 % |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline